RPS6 and hepatocellular carcinoma: An example of the application of RPPA has been reported by Masuda and colleagues, which demonstrated that the level of ribosomal protein S6 phosphorylated at serine residue 235/236 (p-RPS6 S235/236) was most significantly correlated with the resistance of HCC cells to sorafenib.